中国实用外科杂志2017，Vol.37Issue(7)：748-751,4.DOI:10.19538/j.cjps.issn1005-2208.2017.07.10
进展期胰腺癌新辅助治疗后手术时机选择
The optimal time for surgery of locally advanced pancreatic carcinoma treated with neoadjuvant chemotherapy
虞先濬 1程合 1鹿语 1刘辰1
作者信息
- 1. 复旦大学附属肿瘤医院胰腺外科 复旦大学上海医学院肿瘤学系 复旦大学胰腺肿瘤研究所,上海200032
- 折叠
摘要
Abstract
Neoadjuvant therapy is often used in locally advanced pancreatic carcinoma patients in order to down tumor stage, and increase the resectability. However, for the optimal time for surgery after neoadjuvant therapy is still controversy. Surgical resection is recommended for patients who have undergone successful neoadjuvant therapy with reduced stage. Combining prospective and retrospective studies and neoadjuvant treatment data from the authors' center, the paper suggests that the optimal time for surgery is 4-8 weeks after 4-6 cycles of neoadjuvant therapy. For the choice of surgical approach, laparoscopic exploration can be considered to confirm whether metastatic diseases exist and preliminary identification of resectability as well, then for further surgical resection.关键词
进展期胰腺癌/新辅助治疗/手术时机Key words
advanced pancreatic carcinoma/neoadjuvant therapy/optimal time for surgery分类
医药卫生引用本文复制引用
虞先濬,程合,鹿语,刘辰..进展期胰腺癌新辅助治疗后手术时机选择[J].中国实用外科杂志,2017,37(7):748-751,4.
